These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21944002)

  • 21. Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis reveals a new mutation in metastasis.
    Oler G; Ebina KN; Michaluart P; Kimura ET; Cerutti J
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):509-11. PubMed ID: 15807885
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical implications of BRAF mutation in thyroid carcinoma.
    Puxeddu E; Durante C; Avenia N; Filetti S; Russo D
    Trends Endocrinol Metab; 2008; 19(4):138-45. PubMed ID: 18337114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New treatments for metastatic melanoma: a first hope].
    Robert C; Mateus C
    Rev Prat; 2011 Nov; 61(9 Suppl):S1-2. PubMed ID: 22338196
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessing the utility of a mutational assay for B-RAF as an adjunct to conventional fine needle aspiration of the thyroid gland.
    Tetzlaff MT; LiVolsi V; Baloch ZW
    Adv Anat Pathol; 2006 Sep; 13(5):228-37. PubMed ID: 16998316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The complex of aftercare for C-cell carcinoma of the thyroid gland].
    Neumann HP; Zäuner I
    Dtsch Med Wochenschr; 1993 Jan; 118(1-2):25-9. PubMed ID: 8380555
    [No Abstract]   [Full Text] [Related]  

  • 26. [Differenciated thyroid cancer: management and indication of the new targeted therapies].
    Krahenbuhl T; Portmann L; Anchisi S
    Rev Med Suisse; 2012 May; 8(342):1112-7. PubMed ID: 22734180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular mechanism of thyroid carcinogenesis].
    Yamashita S; Mitsutake N
    Nihon Rinsho; 2007 Nov; 65(11):1959-65. PubMed ID: 18018555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RET rearrangements and BRAF mutation in undifferentiated thyroid carcinomas having papillary carcinoma components.
    Mochizuki K; Kondo T; Nakazawa T; Iwashina M; Kawasaki T; Nakamura N; Yamane T; Murata S; Ito K; Kameyama K; Kobayashi M; Katoh R
    Histopathology; 2010 Sep; 57(3):444-50. PubMed ID: 20840674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.
    Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA
    Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
    Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
    Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular medicine in thyroid surgery].
    Moretti S; Barbi F; Tavano M; Calzolari F; Misso C; Lucchini R; Monacelli M; D'Ajello M; Puxeddu E; Avenia N
    Chir Ital; 2008; 60(2):165-78. PubMed ID: 18689164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases.
    Woodford RL; Nikiforov YE; Hunt JL; Bellizzi AM; Zhang X; Mills SE; Stelow EB
    Am J Surg Pathol; 2010 Nov; 34(11):1582-90. PubMed ID: 20924280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is BRAF the Achilles' Heel of thyroid cancer?
    Chiloeches A; Marais R
    Clin Cancer Res; 2006 Mar; 12(6):1661-4. PubMed ID: 16551846
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapy resistance by splicing: can the androgen receptor teach us about BRAF?
    Qi J
    Pigment Cell Melanoma Res; 2012 May; 25(3):293-4. PubMed ID: 22629567
    [No Abstract]   [Full Text] [Related]  

  • 35. [Medullary carcinoma of the thyroid gland].
    Verdy M
    Union Med Can; 1983 Dec; 112(12):1122-3. PubMed ID: 6665952
    [No Abstract]   [Full Text] [Related]  

  • 36. [BRAF gene mutation in thyroid cancer].
    Kopczyńska E; Junik R; Tyrakowski T
    Pol Merkur Lekarski; 2006 Feb; 20(116):210-3. PubMed ID: 16708643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The biology of thyroid oncogenesis.
    Suh I; Kebebew E
    Cancer Treat Res; 2010; 153():3-21. PubMed ID: 19957216
    [No Abstract]   [Full Text] [Related]  

  • 38. Continued targeting of androgen receptor signalling: a rational and efficacious therapeutic strategy in metastatic castration-resistant prostate cancer.
    Bianchini D; de Bono JS
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S189-94. PubMed ID: 21943974
    [No Abstract]   [Full Text] [Related]  

  • 39. A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations.
    Celestino R; Magalhães J; Castro P; Triller M; Vinagre J; Soares P; Sobrinho-Simões M
    Histopathology; 2009 Oct; 55(4):482-7. PubMed ID: 19817905
    [No Abstract]   [Full Text] [Related]  

  • 40. Reply to M. Melo et al.
    Xing M
    J Clin Oncol; 2015 Feb; 33(6):668-9. PubMed ID: 25605859
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.